Belite Bio, Inc.

BLTE·NASDAQ·$142.01Share Price as of 11/2·$6BMarket Cap as of 11/2

Financials

20-FAnnual report (foreign)03/31/26 20-FAnnual report (foreign)03/17/25 20-FAnnual report (foreign)03/12/24 20-FAnnual report (foreign)03/31/23

Disclosures

6-KForeign issuer report10/19/26 6-KForeign issuer report09/08/26 6-KForeign issuer report08/13/26 6-KForeign issuer report08/11/26 6-KForeign issuer report06/15/26

Prospectuses and Registrations

S-8Registration of securities for employees01/30/26 424B5Prospectus supplement12/02/25 424B5Prospectus supplement12/01/25 F-3ASRProspectus / registration10/22/25 424B5Prospectus supplement08/08/25

Proxies

No matching filings.

Ownership

Form 4Insider transaction10/30/26 Form 4Insider transaction10/30/26 Form 4Insider transaction10/30/26 Form 4Insider transaction10/05/26 144Proposed sale of securities10/01/26

Other

EFFECTRequest for effectiveness05/30/23 CORRESPCorrespondence with the SEC05/25/23 UPLOADLetter from the SEC05/25/23 EFFECTRequest for effectiveness05/09/23 CORRESPCorrespondence with the SEC05/05/23